Veeva Systems (NYSE: VEEV) and IQVIA (NYSE: IQV) announced an expanded partnership. IQVIA, a leading global provider of clinical research services, will standardize its clinical operations on four Veeva applications: Clinical Trial Management System (CTMS), eTMF, Study Startup, and Site Connect. IQVIA will use the applications for its clinical development studies.
The expanded partnership builds on the companies’ previous collaboration on electronic data capture (EDC). The integration aims to accelerate clinical trials, improve efficiency, and strengthen site centricity.
Sponsors seeking a complete Veeva technology stack will be able to access all of Veeva’s clinical solutions through IQVIA.